Señales en vivo de KDEV.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 11:17):

Stats
Volumen de hoy	88 300.00
Volumen promedio	134 203
Capitalización de mercado	422.30M
EPS	SEK0 ( 2024-02-14 )
Próxima fecha de ganancias	( SEK0 ) 2024-05-16
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	79.00
ATR14	SEK0.00700 (0.44%)

Volumen Correlación

Largo: -0.02 (neutral)

Corto: -0.95 (very strong negative)

Signal:(52.533) Neutral

Karolinska Development AB Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Karolinska Development AB Correlación - Moneda/Commodity

0.07
( neutral )

0.00
( neutral )

-0.07
( neutral )

Karolinska Development AB Finanzas

Annual	2023
Ingresos:	SEK2.81M
Beneficio Bruto:	SEK2.81M (100.00 %)
EPS:	SEK0.0200

FY	2023
Ingresos:	SEK2.81M
Beneficio Bruto:	SEK2.81M (100.00 %)
EPS:	SEK0.0200

FY	2022
Ingresos:	SEK2.30M
Beneficio Bruto:	SEK2.30M (100.00 %)
EPS:	SEK-0.560

FY	2021
Ingresos:	SEK2.17M
Beneficio Bruto:	SEK0.00 (0.00 %)
EPS:	SEK0.859

Financial Reports:

No articles found.

Karolinska Development AB

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.